Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Malaria : Alterations of the host cells: 1. A visible change of shape and reduced
deformability 2. The presence of electron- dense protrusion/knobs 3. Small
depression/caveolae at the surface pf RBC connected by a network of small
vesicles and clefts in P.vivax and P.ovale 4. Cytoadherence to endothelial cells 5.
Adherence to N erythrocyte : rosetting ; to infected erythrocyte : clumping 6.
Presence of new metabolic channels --) increased membrane permeability,
increased intake of nutrients, or escape from immunity by sequestration.
Pathogenesis : asexual stages(Gametocytes not involve in pathogenesis)
Pathology : -Hemolysis : direct invasion & rupture of RBC during erythrocytic
cycle ; Increased osmotic fragility of RBC
-Increased adhesiveness of
infected RBC: increased with maturity of parasite (schizont>trophozoite) ; Knob
theory -Release of pyrogens, toxin and cytokines -Immunological responses
-Capillary permeability -Tissue hypoxia
Pathogenesis : -Cytoadherence -infected RBCs will adhere to the endothelium as
well as to each other -High cytokine levels induce expression of endothelial
adhesions: inflammation makes the endothelial sticker -Cytokines can mimic
many of the symptoms of malaria : shivering,headache, chills, spiking of
fever,sweating,vasodilation,hypoglycemia -Adherence and Inflammation
reinforce each other in an unholy circle causing pathology 0
Immunity influenced by : genetics, age, health condition, pregnancy status,
intensity of transmission in region, length of exposure, maintenance of exposure
Immunity : Innate :: Red cell polymorphism associated with some protection -) Hb
S sickle cell -)Hb C and E -) Thalassemia a and B -) G6PD
Red cell membrane
changes : absence of certain Duffy coat antigens improve resistance to P vivax
: Acquired ::
Transferred from mother to child -) 3-6mos protection -) Then the children have
increased susceptibility
Increased susceptibility during early childhood : Hyper and holoendemic areas -)
By age 5 attacks usually < frequent and severe -) can have >parasite densities
with fewer sx :Meso - or hypoendemic areas : less transmission and repeated
attacks May acquired partial immunity and be at higher risk for symptomatic
disease as adults
No complete immunity :can be parasitemic without clinical disease
Need long period of exposure for induction May need continued exposure for
maintenance
Immunity can be unstable :can wane as one spends time outside endemic area
can change with movement to area with different endemicity decreases during
pregnancy,risk improves with increasing gravidity
Immune mechanisms :
Anti sporozoite antibodies in adults in endemic areas -) blocks liver invasion
Anti sporozoite/merozoite antibodies -) block RBC invasion
Wuchereria bancrofti
Culex ,Anopheles, Aedes
F>M (>Brugia malayi)
(rambut)
Cephalic : L=W
Inti : teratur
Ekor: runcing inti-ve
Badan : smooth
Tungkai atas dan bawah
(termasuk paha)
Genital(dancing worm on
usg)
Mammae
Stadium Inflammation :
Fever, Lymphangitis,
Lymphadenitis
Stadium Obstruction :
Lymph varices on axillae,
inguinal, gnital,
hydrocele
Microfilaria ob blood
film : Giemsa, H&E.
Centrifugation of blood
dissolve in Formalin2%
(Knott) / filtration through
nucleopore membrane
Antigen :
Immunochromatographic
test(only W bancrofti)
Biopsy PCR
mosquitoes
Cacing dewasa -hidup di
Lymph
*ingest L3 larvae to a
person
Microfilaria (d) (Nocturnal
Period : 10pm-2am)
Clinical Manifestation
Diagnosis
Brugia malayi
Mansonia(desa),
Anopheles(kota)
(F>M) <W bancrofti (white
thread)
Cephalic : l=2W
Inti : kasar x teratur
Ekor : runcing 2inti
Badan : patah-patah
Below the knee
scrotal
DEC(diethylcarbamazapi
ne)
short-term : 5mg/BW
->6d
Long-term : 3-4mg/BW
->10d
Elephantiasis :
compression
surgery(shunt
nodovenous) , raise the
leg up, stocking, leg
treatment
Treatment
*DEC prophylaxis6mg/bw/day for 2d
monthly
1)DEC+Ivermectin(no
microfilariacidal effect)
: 6mg/bw/24h for 12d or
divided dose : 1st-3rd (13mg/Bw/24h
4th-12th(13mg/bw/12h)
2)Albendazole(400
microgr/bw)
+ Ivermectin
3)Albendazole +DEC
Classification :
Grade I : pitting edema + , dismiss spontaneously by applying pressure
Grade II : non pitting edema, not affected by pressure applied
Grade III (elephantiasis) : Grade II + dermatosclerosis + papilomatous
Rubella
Cytomegalovir
us
Herpes
-German measles
family:Toga
Genus:rubivirus
Transmission :
a.Incubation : 23wks
b.Highly
contagious
c.Spread through
naso secrection
d.Transplacental
tx likely
Physical: 3d rash,
swollen grand,
low-grade fever,
joint pain,LOA
Rubella effects:
A.Maternal:
miscarriage and
stillbirth. The risk
of congenital
rubella > 1st
trimester
B. Neonatal :
Cataract, Cardiac
abnormalities,
Deafness, mental
retardation,
movement
disorder,
balancing
problem,
blueberry muffin
spots
Diagnosis : Amniocentesis
-PCR, Ultrasound measure
the level of antibodies
Diagnosis of
Congenital RS :
IgM in
newborn*IgM x
cross placenta
Manifestation of cT :
Hepatosplenomegaly
Chorioretinitis
CNS injury : CT scan with
In herpes
family HHV5
Transmission :
a.
Transplacentall
y
b.Human milk
c.Blood
transfusion or
organ
transplant
d. urine or
saliva
CMV effects:
A. Maternal :
mostly
asymptomatic
B. Neonatal :
Jaundice,
petechiae,
hepatosplenom
egaly,
microcephaly,
chorioretinitis
sequelae :
Sezuire,
chorioretinitis,
periventricular
calcification,
Sensorineural
deafness,
motor deficit
5-7% of
newborns with
asymptomatic
congenital CMV
develop
neurological
sequelae(heari
ng loss>)
Diagnosis:
Isolation of
virus from
urine,saliva,
CSF, blood in
HHV2 or HSV2
Transmission:
a.Maternal
genital
b.Ascending
infection if
ROM
*Postnatal
:HSV1 :herpetic
whitlow
Risk:
premature,ROM
>6h, fetal scalp
monitoring
Congenital HSV
Skin vesicles,
Chorioretinitis,
Microcephaly,
Microophthalmi
a, IUGR
1.Skin,Eye,Mou
th
-1st-2nd week
presentation
-Limited to
skin,eye,mouth
/mucous
membrane
-Neurologic
sequelae
Ophthalmology
involved
2.CNS
-Early - 3rd
week
Encephalitis(te
mporal)
3.Disseminated
Hepatitis,
Pneumonitis,DI
C
multiple intracranial,
calcification Hydrocephaly
Seizure Cerebral palsy
Mental retardation
Jaundice
Premature birth or stillbirth
Manifestation of T in human :
-Most are asymptomatic,
mimic mononucleosis
-Acute T: Influenza-like
symptoms, Swollen lymph
nodes, Muscle aches
latent T : bradyzoite forming
cyst in muscle and nervous
Cutaneous and Psychiatric
Diagnosis : may be difficult,
trial of therapy
with(Pyri,sulfa,leuco),
Serology : IgG IgM
Treatment :
1.Infected women :
Fetal infection not confirmed
yet: Spiramycin(1st
trimester): reduce
transmission
Fetus infected confirmed:
3 weeks :Pyrimethamine
1x50mg PO
Sulfadiazine 3x1gr
Alternating 3wks: Spiramycin
3x1gr
until delivery
2.Newborn :
Pyrimethamine 1mg/kg/day
for2-6months --> 1mg/kg
complete 1 yr
Sulfadiazine: 50mg/kg BID
-1yr
Leucovorine: 10mg every
3x/wks, to prevent toxicity of
P
28d of vaccinated,
avoid contact with
rubella ppl)
Vaginal
delivery risk in
mom with
herpes:
1st
symptomatic
lesion>
asymptomatic
but newly
infected>
recurrent> past
history
Diagnosis :
Culture :
Mouth>eyes,
skin
Culture:
stool,urine,CSF
DFA
PCR :
Diss>CNS>SE
M
Treatment :
Acyclovir
SEM:
60mg/kg/8h for
14d
Dissem and
CNS:
60mg/kg/8h for
21d
Smallpox
7-17d incubation
Fever, severe systemic sx preceded rash by
2-3days
Lesions mostly on face, arms, legs
Palms and soles involved
Lesions at same stage of development
Scabs form 10-14d after rash appear
Vesicles do not collapse on puncture